The life sciences industry faces challenging times due to a number of external factors driving change.

• Litigation and the actions of regulators continue to pose a financial and reputation threat to many companies in the sector.

• Successful challenges to patents and other forms of intellectual property can quickly undermine a firm’s core product and source of revenue.

• Meanwhile, the insurance community is increasingly restricting Product Liability insurance cover for life sciences companies.

Our understanding of the special risks facing life sciences companies has made Marsh the leading broker servicing the sector.

We provide risk management services and solutions for companies engaged in pharmaceuticals, biotechnology, medical device manufacturing, healthcare, provision of specialist services such as contract research, analytical laboratories and educational institutions engaged in clinical research.

Marsh has created Centres of Excellence to aggregate our knowledge and expertise of the industry, stay abreast of current economic trends impacting the industry and provide cutting-edge insights and solutions in areas of programme design, placement, service and administration. One such Centre of Excellence exists in the UK.

In partnership with our wider network of MMC companies, we provide solutions and services such as:

• business risk consulting
• supply chain management
• clinical trials risk
• business continuity planning.

We have the right experts and state-of-the-art risk management tools and solutions to help our clients successfully navigate the world of risk.